1. Home
  2. ADTN vs CERS Comparison

ADTN vs CERS Comparison

Compare ADTN & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADTRAN Holdings Inc.

ADTN

ADTRAN Holdings Inc.

HOLD

Current Price

$7.27

Market Cap

684.4M

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.54

Market Cap

585.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADTN
CERS
Founded
1985
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
EDP Services
Sector
Telecommunications
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
684.4M
585.1M
IPO Year
1996
1996

Fundamental Metrics

Financial Performance
Metric
ADTN
CERS
Price
$7.27
$2.54
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$15.50
N/A
AVG Volume (30 Days)
1.8M
2.1M
Earning Date
05-04-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
90.83
27.27
EPS
N/A
N/A
Revenue
$1,083,807,000.00
$51,326,000.00
Revenue This Year
$11.09
$19.95
Revenue Next Year
$8.47
$8.84
P/E Ratio
N/A
N/A
Revenue Growth
17.46
30.68
52 Week Low
$7.11
$1.17
52 Week High
$19.98
$3.47

Technical Indicators

Market Signals
Indicator
ADTN
CERS
Relative Strength Index (RSI) 33.24 45.88
Support Level $7.43 $2.37
Resistance Level $8.81 $2.68
Average True Range (ATR) 0.29 0.11
MACD 0.12 -0.01
Stochastic Oscillator 5.01 15.53

Price Performance

Historical Comparison
ADTN
CERS

About ADTN ADTRAN Holdings Inc.

Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions segment, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support segment, which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions. It generates the majority of its revenue from the Network Solutions segment.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety, and generates revenue from the same.

Share on Social Networks: